Search results :

Clobetasol

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: D07AD01

Side effects

Options: Hide MedDRA Preferred Terms ,   display only 20 labels

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Infection Infection 10% - 14.2% x x
Secondary infection x x x x x x x x x x x x x x x x x
Infestation Infestation NOS 10% - 14.2% x x
Application site pain Application site burn 10% - 46.7% x x x x x
Application site pain 0.833% - 1.67% x x
Application site burn Application site burn 10% - 46.7% x x x x x
Upper respiratory tract infection Upper respiratory tract infection 1.67% - 8.33% x x
Discomfort Discomfort 1.3% - 12.6% x x x x x x
Skin atrophy Skin atrophy 4.2% x x x x x x x x x x x x x x x x x x x
Nasopharyngitis Nasopharyngitis 2.5% - 5% x x
Telangiectasia Telangiectasia 3.2% x x x x x x x x x x x x x x x x x
Application site pruritus Application site pruritus 2.5% - 3.33% x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue 1.67% - 3.33% x x
Headache Headache 0.787% - 1.79% x x x
Instillation site pain Application site pain 0.833% - 1.67% x x
Dry skin Dry skin 1% x x x x x x x
Influenza Influenza 0% - 1.67% x
Asteatosis Asteatosis 0% - 1.67% x x
Pruritus Pruritus postmarketing, 0.538% - 7.09% x x x x x x x x x x x x x x x x x x x x x
Application site dryness Application site dryness 0% - 1.67% x x x x x
Pharyngitis streptococcal Pharyngitis streptococcal 0% - 0.833% x x
Application site atrophy Application site atrophy 0% - 0.833% x x
Application site irritation Application site irritation 0% - 0.833% x x
Application site discolouration Application site pigmentation changes 0% - 0.833% x x
Alopecia Alopecia postmarketing x x x x x
Cushing's syndrome Cushing's syndrome postmarketing x x x x x x x x x x x x x x x x x x x
Dermatitis contact Dermatitis contact postmarketing x
Allergic contact dermatitis postmarketing x x x x x x x x x x x x x x x x x
Dermatitis irritant contact x x x
Dizziness Dizziness postmarketing x
Endocrine disorder Endocrine disorder postmarketing x x x
Dermatitis Rash postmarketing x x x x
Dermatitis x
Dermatitis perioral x x x x x x x x x x x x x x x x x
Rash Rash postmarketing x x x x
Excoriation Excoriation postmarketing x x
Lichenification Lichenification postmarketing x x
Nausea Nausea postmarketing x
Pain Pain postmarketing x
Stinging x x x x x x x x x x x x x x x x x x x
Psoriasis Psoriasis postmarketing x x x
Erythema Erythema postmarketing x x x x x x x x x x x x x x x x x
Urticaria Urticaria postmarketing x x x x
Eye pain Eye pain postmarketing x
Skin irritation Skin irritation postmarketing x
Eye irritation Eye irritation postmarketing x x
Skin exfoliation Skin exfoliation postmarketing x x x
Localized exfoliation postmarketing x
Pain of skin Pain of skin postmarketing x x x
Skin tightness Skin tightness postmarketing x
Secondary adrenocortical insufficiency Secondary adrenocortical insufficiency postmarketing x x x x x x
Induration Induration postmarketing x x
Vision blurred Vision blurred postmarketing x
Hair colour changes Hair colour changes postmarketing x
Skin fissures Chapped skin postmarketing x x
Oedema Oedema x x x
Folliculitis Folliculitis x x x x x x x x x x x x x x x x x x x x
Glycosuria Glycosuria x x x x x x x x x x x x
Hyperglycaemia Hyperglycaemia x x x x x x x x x x x x
Hypertrichosis Hypertrichosis x x x x x x x x x
Miliaria Miliaria x x x x x x x x x x x x x x x x x
Burning sensation Burning sensation x x x
Application site reaction Application site reaction x
Skin striae Skin striae x x x x x x x x x x x x x x x x x
Leukoderma Leukoderma x x x x x x x x x x x x x x x x x
Dermatitis acneiform Acneiform eruption x x x x x x x x x x x x x x x
Tenderness Tenderness x x x x x
Rash pustular Pustule x
Atopy Atopy x
Hypoaesthesia Numbness in fingers x x x x x x x x x x
Paraesthesia Tingling sensation x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CLOBETASOL

Side effects:23
Source:FDA Structured Product Label

CLOBETASOL

Side effects:26
Source:FDA Structured Product Label

clobetasol

Side effects:8
Source:FDA Structured Product Label

Clobetasol

Side effects:22
Source:FDA Structured Product Label

CLOBETASOL

Side effects:19
Source:FDA Structured Product Label

clobetasol

Side effects:21
Source:FDA Structured Product Label

CLOBETASOL

Side effects:14
Source:FDA Structured Product Label

Clobetasol

Side effects:11
Source:FDA Structured Product Label

CLOBETASOL

Side effects:15
Source:FDA Structured Product Label

Clobetasol

Side effects:15
Source:FDA Structured Product Label

Clobetasol

Side effects:16
Source:FDA Structured Product Label

CLOBETASOL

Side effects:17
Source:FDA Structured Product Label

clobetasol

Side effects:17
Source:FDA Structured Product Label

Clobetasol

Side effects:17
Source:FDA Structured Product Label

CLOBETASOL

Side effects:17
Source:FDA Structured Product Label

CLOBETASOL

Side effects:18
Source:FDA Structured Product Label

CLOBETASOL

Side effects:21
Source:FDA Structured Product Label

CLOBETASOL

Side effects:21
Source:FDA Structured Product Label

CLOBETASOL

Side effects:22
Source:FDA Structured Product Label

CLOBETASOL

Side effects:21
Source:FDA Structured Product Label

CLOBETASOL

Side effects:21
Source:FDA Structured Product Label

CLOBETASOL

Side effects:31
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label